• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Dyax Corp. (DYAX) - Financial and Strategic SWOT Analysis Review - Product Image

Dyax Corp. (DYAX) - Financial and Strategic SWOT Analysis Review

  • Published: April 2014
  • 50 pages
  • GlobalData

FEATURED COMPANIES

  • CSL Behring
  • Genentech, Inc.
  • Novo Nordisk A/S
  • Pharming Group N.V.
  • Shire Plc
  • ViroPharma Incorporated
  • MORE

Dyax Corp. (DYAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of READ MORE >

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Dyax Corp. - Key Facts
Dyax Corp. - Key Employees
Dyax Corp. - Key Employee Biographies
Dyax Corp. - Major Products and Services
Dyax Corp. - Pharmaceutical Pipeline Products Data
Dyax Corp., Pipeline Products by Therapy Area
Dyax Corp., Pipeline Products by Development Phase
Dyax Corp. - Medical Equipment Pipeline Products Data
Dyax Corp. Pipeline Products by Equipment Type
Dyax Corp. Pipeline Products by Development Stage
Dyax Corp. - History
Dyax Corp. - Company Statement
Dyax Corp. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Dyax Corp. - Business Description
Dyax Corp. - SWOT Analysis
SWOT Analysis - Overview
Dyax Corp. - Strengths
Strength - Licensing and Funded Research Program
Strength - Innovative Product and Technology
Strength - Healthy Liquidity Position
Dyax Corp. - Weaknesses
Weakness - Dependence on Third Party Manufacturers
Weakness - History of Losses
Dyax Corp. - Opportunities
Opportunity - Business Initiatives
Opportunity - Strategic Agreements
Opportunity - Increasing Healthcare Expenditure in the US
Opportunity - Emerging Markets
Dyax Corp. - Threats
Threat - Competition and Technological Changes
Threat - Uncertainties in R&D
Threat - Stringent Regulations
Dyax Corp. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Dyax Corp., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Dyax Corp., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Dyax Corp., Medical Equipment, Deals By Year, 2008 to YTD 2014
Dyax Corp., Medical Equipment, Deals By Type, 2008 to YTD 2014
Dyax Corp., Recent Deals Summary
Section 5 – Company’s Recent Developments
Dyax Corp., Recent Developments
Feb 28, 2014: Dyax Announces Fourth Quarter and Full Year 2013 Financial Results
Nov 26, 2013: Dyax Corp. to participate in the 2013 Deutsche Bank BioFEST Conference
Oct 22, 2013: Dyax Announces Third Quarter 2013 Financial Results
Oct 15, 2013: Dyax to Host Third Quarter 2013 Earnings Call and Webcast
Sep 05, 2013: Dyax to Participate in the Morgan Stanley Global Healthcare Conference
Jul 17, 2013: Dyax to Host Second Quarter 2013 Earnings Call and Webcast
Apr 29, 2013: Dyax to Participate in the Needham Healthcare Conference
Apr 25, 2013: Dyax Reports Revenue Of $12m In Q1 2013
Mar 12, 2013: Dyax to Participate in the 25th Annual ROTH Conference
Mar 08, 2013: Dyax's COO Ivana Magovcevic-Liebisch To Resign
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Dyax Corp., Key Facts
Dyax Corp., Key Employees
Dyax Corp., Key Employee Biographies
Dyax Corp., Major Products and Services
Dyax Corp., Number of Pipeline Products by Therapy Area
Dyax Corp., Number of Pipeline Products by Development Stage
Dyax Corp., Pipeline Products By Therapy Area and Development Phase
Dyax Corp. Number of Pipeline Products by Equipment Type
Dyax Corp. Pipeline Products by Equipment Type
Dyax Corp. Number of Pipeline Products by Development Stage
Dyax Corp. Pipeline Products by Development Stage
Dyax Corp., History
Dyax Corp., Subsidiaries
Dyax Corp., Key Competitors
Dyax Corp., Ratios based on current share price
Dyax Corp., Annual Ratios
Dyax Corp., Interim Ratios
Dyax Corp., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Dyax Corp., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Dyax Corp., Medical Equipment, Deals By Year, 2008 to YTD 2014
Dyax Corp., Medical Equipment, Deals By Type, 2008 to YTD 2014
Dyax Corp., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Dyax Corp., Pipeline Products by Therapy Area
Dyax Corp., Pipeline Products by Development Phase
Dyax Corp. Pipeline Products by Equipment Type
Dyax Corp. Pipeline Products by Development Stage
Dyax Corp., Performance Chart (2009 - 2013)
Dyax Corp., Ratio Charts
Dyax Corp., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Dyax Corp., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Dyax Corp., Medical Equipment, Deals By Year, 2008 to YTD 2014
Dyax Corp., Medical Equipment, Deals by Type, 2008 to YTD 2014

XOMA Ltd.
BioInvent International AB
Novo Nordisk A/S
Shire Plc
ViroPharma Incorporated
Genentech, Inc.
Pharming Group N.V.
CSL Behring

Note: Product cover images may vary from those shown

RELATED PRODUCTS